Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are essentially the most maturely created TPD strategies. In this critique, we concentrate on each preclinical experiments and scientific trials to provide an extensive summary of the safety and medical effectiveness of PROTACs and MGDs in hematologic malignancies over the past twenty https://zionqzgk29629.jts-blog.com/30882809/about-syrosingopine